‘There’s Never Been More Attention on the Ills of Profit-Motivated Pharmaceutical Production’

“We see high prices, recurring shortages and declining innovation, but also these issues about drug safety and mass marketing, as the natural outcomes of an industry that is oriented around the singular goal of maximizing profit.”

"We see high prices, recurring shortages and declining innovation, but also these issues about drug safety and mass marketing, as the natural outcomes of an industry that is oriented around the singular goal of maximizing profit."
Print Share Comment Cite Upload Translate
CITATION GOES HERE CITATION GOES HERE
Select a language: